Gerard Bannenberg, Ph.D.

GB-082814-retro-touchEditor

Gerard Bannenberg is an experimental scientist specializing in polyunsaturated fatty acids and their mechanisms of action. He is working as Director of Compliance and Scientific Outreach at the Global Organization for EPA and DHA omega-3s (GOED).

Gerard Bannenberg has published some 50 studies related to poly-unsaturated fatty acid-derived lipid mediators and on the mechanisms whereby the body regulates inflammation and protects itself from oxidative injury. He is an affiliate member of the Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, at Brigham & Women’s Hospital, Boston MA. He has worked as scientific officer at Solutex, a Spanish high-technology company producing highly defined EPA and DHA concentrates. He has also served as a board member of GOED.

Gerard received a Ph.D. in Toxicology at the Institute for Environmental Medicine at the Karolinska Institute in Stockholm, Sweden, and his undergraduate degree at the Centre for Bio-Pharmaceutical Sciences at Leiden University, The Netherlands. He also co-founded the European Workshop on Lipid Mediators, a series of short congresses dedicated to promoting the understanding of bioactive lipid mediators, and the European Society for Lipid Mediators. He is a reviewer of scientific articles for several journals.

Select Publications:

Omega-3 Long-Chain Polyunsaturated Fatty Acid Content and Oxidation State of Fish Oil Supplements in New Zealand. Bannenberg G, Mallon C, Edwards H, Yeadon D, Yan K, Johnson H, Ismail A.  2017. Sci. Rep. 7(1):1488.

Publication of the special issue “Fourth European Workshop on Lipid Mediators”. Clària J, Norel X, Bannenberg G 2013. Prostaglandins Other Lipid Mediat 107; 1-3.

Specialized pro-resolving lipid mediators in the inflammatory response: An update. Bannenberg G, Serhan CN 2010. Biochim Biophys Acta 1801 12; 1260-1273.

Resolvins: Current understanding and future potential in the control of inflammation. Bannenberg GL 2009. Curr Opin Drug Discov Devel 5; 644-658.

2009.  Functional analysis of alpha-DOX2, an active alpha-dioxygenase critical for normal development in tomato plants. Bannenberg G, Martínez M, Rodríguez MJ, López MA, Ponce de León I, Hamberg M, Castresana C. Plant Physiol. 151, 3; 1421-1432.

Endogenous receptor agonists: resolving inflammation. Bannenberg G, Arita M, Serhan CN 2007. Scientific World Journal 7; 1440-1462.

Molecular circuits of resolution: formation and actions of resolvins and protectins. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN 2005.   J Immunol. 174, 7; 4345-4355.

Leukotriene C4 is a tight-binding inhibitor of microsomal glutathione transferase-1. Effects of leukotriene pathway modifiers. Bannenberg G, Dahlén SE, Luijerink M, Lundqvist G, Morgenstern R 1999.   J Biol Chem. 274, 4; 1994-1999.

Lipid peroxidation and protein thiol depletion are not involved in the cytotoxicity of N-hydroxy-2-acetylaminofluorene in isolated rat hepatocytes. Kroese ED, Bannenberg G, Dogterom P, Noach AB, Nagelkerke JF, Meerman JH 1990. Biochem Pharmacol. 40, 8; 1885-1892.

 

2 thoughts on “Gerard Bannenberg, Ph.D.

Leave a Reply

Your email address will not be published. Required fields are marked *